CHIANG KYLE

PrivateCIK: 1831341
Location

LEXINGTON, MA

CHIANG KYLE enters LOGICBIO THERAPEUTICS, INC. with 17K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderCHIANG KYLECIK 1831341
Officer· Chief Operating Officer
Since Nov 2020
17K
Baseline shares
100% direct
17K
Direct ownership
1 position
116.24K
Derivative underlying
6 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Common Stock

Direct
Shares owned17K
Total
17K direct17K
Derivative Holdings6

Option to purchase Common Stock

Direct
Underlying security
Common Stock

Underlying shares

23K

Shares owned

N/A

Exercise price

10.10

Expiration

Exercise window

Restricted Stock Units

Direct
Underlying security
Common Stock

Underlying shares

9.36K

Shares owned

N/A

Exercise price

0.00

Expiration

Exercise window

Option to purchase Common Stock

Direct
Underlying security
Common Stock

Underlying shares

8K

Shares owned

N/A

Exercise price

0.50

Expiration

Exercise window

Option to purchase Common Stock

Direct
Underlying security
Common Stock

Underlying shares

28.92K

Shares owned

N/A

Exercise price

7.11

Expiration

Exercise window

Option to purchase Common Stock

Direct
Underlying security
Common Stock

Underlying shares

22.91K

Shares owned

N/A

Exercise price

0.73

Expiration

Exercise window

Option to purchase Common Stock

Direct
Underlying security
Common Stock

Underlying shares

24.05K

Shares owned

N/A

Exercise price

0.73

Expiration

Exercise window

Total

Underlying

116.24K

Owned

0.00

CHIANG KYLE — Initial Ownership Disclosure (Form 3) Filed Nov 12, 2020 | Finecho